Loading the records…
Loading the records…
S.1031 (ROCR Value Based Program Act) is an early-stage bill proposing a shift to bundled Medicare payments for radiation oncology. It presents a structural long-term bearish signal for equipment vendors like GE HealthCare ($GEHC) but has no near-term market impact due to its early legislative stage and absence of funding. $GEHC is already down 16% in 30 days, trading at $59.66 near its 52-week low of $58.75.
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
GE HealthCare ($GEHC) is the most directly exposed U.S.-listed pure-play to radiation oncology capital equipment. The stock's current price of $59.66 near its 52-week low reflects broader medical device sector weakness, not this bill. However, if S.1031 gains legislative momentum — such as a committee hearing or CBO cost estimate — it would add a specific regulatory overhang that could drive further downside. Investors should monitor the Senate Finance Committee calendar for any action on this bill. No other publicly traded U.S. companies have direct and material exposure to this specific policy mechanism at the level required for a confident causal chain.
The ROCR Value Based Program Act (S.1031) was introduced in the Senate on March 13, 2025, by Sen. Tillis (R-NC) with four cosponsors, and referred to the Committee on Finance. It has a House companion bill (HR2120). The bill proposes replacing the current fee-for-service Medicare payment structure for radiation oncology with episode-based bundled payments, where a single payment covers the entire course of radiation therapy for a cancer patient rather than paying per procedure. The bill also includes a new exception for free or discounted patient transportation.
The money trail is nonexistent at this stage — the bill authorizes no funding, and any future Medicare payment changes would affect the roughly $4.2 billion in annual Medicare spending on radiation oncology services cited in the bill's findings. Authorization by this bill would set policy, but actual implementation requires CMS rulemaking and does not involve direct federal spending through appropriations.
Structural winners and losers: If enacted, this bill is structurally bearish for capital equipment vendors that sell linear accelerators, CT simulators, and radiation therapy planning systems to U.S. hospitals and freestanding centers. GE HealthCare ($GEHC) is the most directly affected publicly traded pure-play, as its imaging and precision care businesses include radiation oncology equipment. Varian Medical Systems (now part of Siemens Healthineers, which trades OTC as $SMMNY) is a more exposed pure-play but not listed on a U.S. exchange. Diversified hospital operators like HCA Healthcare ($HCA) and Tenet ($THC) would face margin compression from bundled payments reducing per-procedure revenue, though volume effects could offset this.
Real market data confirms $GEHC is already under severe pressure: trading at $59.66 as of April 30, 2026, down 13.3% in the last 7 days and 16.2% in the last 30 days. The stock is just $0.91 above its 52-week low of $58.75. The current selloff appears driven by broader market or sector factors (medical device selloffs, earnings, or macro) rather than this bill, which has not advanced since introduction.
Timeline: The bill has had zero legislative action since referral to the Senate Finance Committee 13 months ago. With 4 cosponsors and a companion bill in the House, it has some bipartisan support but no committee markups scheduled. The 119th Congress runs through January 2027, so the window for passage is contracting. Measurable market impact would only occur if the bill advances to committee hearings or a CBO score, which has not happened.
Matched on shared policy language across AI analyses, with ticker & timing weight
VARIAN MEDICAL SYSTEMS, INC: $32.8M Department of Health and Human Services Federal Award
ELEKTA INC: $10.7M Department of the Interior Contract
Executive orders & memoranda affecting the same sectors or companies
This executive order establishes a Women's Health Division within the NIH to coordinate and accelerate research on understudied women's health conditions, and creates a White House Women's Health Task Force to drive policy reforms and translation of research into clinical practice across federal agencies. It directs specific agencies to prioritize research, data collection, and translation into prevention, diagnosis, and treatment, with a focus on all life stages from infancy through aging.
This executive order directs the Secretaries of State, Labor, and Homeland Security to coordinate with Commerce, Education, and the SBA when processing H-1B petitions, and requires them to consider whether the employer has engaged in layoffs of similarly situated U.S. workers within the past year. It also orders the Labor Department to review past labor condition applications for potential enforcement actions against sponsoring employers, effectively tightening scrutiny on H-1B usage, especially by outsourcing firms.
This proclamation orders the Secretaries of War and Veterans Affairs to mandate rapid, ongoing digital sharing of military personnel and medical records, deploy AI-powered tools for benefits applications, and update existing IT contracts for interoperability. It also requires the Transition Assistance Program to connect separating service members to specific jobs or training programs before discharge.
Free — no credit card
HillSignal scores every Congressional bill, federal contract, and insider filing for market impact and emails you the high-conviction ones — free, no credit card.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →